glp 1 drugs adverse effects GI of Glucagon-Like Peptide-1 Receptor Agonists Clinical Focus on GLP-1 Agonists

doi: 10.1074/jbc.M500540200 [DOI] [PubMed] [Google Scholar] 115

The Lancet Diabetes & Endocrinology, 6 (3), 237248

Qualifying for insurance coverage of brand-name medications through type 2 diabetes or cardiovascular indications rather than weight loss alone can also dramatically reduce costs

They slow gastric emptying, so food sits in the stomach longer and satiety signals last longer

Patients with atrial arrhythmias had risk factors for occurrence and continuation of arrhythmias: they were significantly older, more often had obesity, a history of AF and LV hypertrophy and were current tobacco users

Neurochem Int 128:94105